BTG (BTG)

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

705.50p
   
  • Change Today:
      9.50p
  • 52 Week High: 729.00
  • 52 Week Low: 396.60
  • Currency: UK Pounds
  • Shares Issued: 362.80m
  • Volume: 577,053
  • Market Cap: 2,559.58m
  • Beta: 1.25

BTG Overview

BTG is a specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists.

1 Day Chart (22-10-2014)

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 9.4% 17.2%
ROCE 27.4%  
Latest F'cast
P/E 48.7 47.2
PEG n/a 15.4
Pr/Revenue 8.8 7.4
Pr/Book 4.8  
Latest F'cast
Revenue 24.3% 18.7%
PBT 38.2% 78.4%
EPS n/a 3.1%
DPS n/a n/a

BTG Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-10 98.50 9.10 6.90p 25.8 0.0 +527% n/a 0.0%
31-Mar-11 111.40 (10.80) 1.00p 227.6 n/a -86% n/a 0.0%
31-Mar-12 197.00 23.00 11.40p 29.3 0.0 +1,040% n/a 0.0%
31-Mar-13 233.70 24.10 14.50p 24.6 0.9 +27% n/a 0.0%
31-Mar-14 290.50 33.30 14.50p 37.4 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

BTG Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-15 344.68 59.40 14.94p 47.2 15.4 +3% n/a 0.0%
31-Mar-16 397.55 92.24 21.80p 32.4 0.7 +46% n/a 0.0%

Copyright © 2014 FactSet Research Systems Inc. All rights reserved.

BTG Company Announcements

BTG to supply DC Bead® and Bead Block® 13-Oct-2014 07:00 RNS
Settlement regarding CroFab(R) patent litigation 10-Oct-2014 12:00 RNS
Holding(s) in Company 08-Oct-2014 17:11 RNS

Latest BTG Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

BTG Market Data

Currency UK Pounds
Share Price 705.50p
Change Today 9.50p
% Change 1.36 %
52 Week High 729.00
52 Week Low 396.60
Volume 577,053
Shares Issued 362.80m
Market Cap 2,559.58m
Beta 1.25

BTG Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
97.73% below the market average97.73% below the market average97.73% below the market average97.73% below the market average97.73% below the market average
90.7% below the sector average90.7% below the sector average90.7% below the sector average90.7% below the sector average90.7% below the sector average
Price Trend
96.07% above the market average96.07% above the market average96.07% above the market average96.07% above the market average96.07% above the market average
88.46% above the sector average88.46% above the sector average88.46% above the sector average88.46% above the sector average88.46% above the sector average
Income Not Available
Growth
77.43% above the market average77.43% above the market average77.43% above the market average77.43% above the market average77.43% above the market average
89.74% above the sector average89.74% above the sector average89.74% above the sector average89.74% above the sector average89.74% above the sector average

What The Brokers Say

Strong Buy 5
Buy 0
Neutral 2
Sell 0
Strong Sell 3
Total 10
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

BTG Dividends

No dividends found

Trades for 22-Oct-2014

Time Volume / Share Price
16:55 2,054 @ 705.21p
16:35 457 @ 705.50p
16:35 106,445 @ 705.50p
16:29 27,289 @ 707.22p
16:29 30 @ 704.50p

BTG Key Personnel

CEO Louise Makin
CFO Rolf Soderstrom
Chair Garry Watts

Top of Page